Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Beta-blocker use is associated with fragility fractures in postmenopausal women with coronary heart disease.
Sosa M, Saavedra P, Gómez de Tejada MJ, Mosquera J, Pérez-Cano R, Olmos JM, Muñoz-Torres M, Amérigo MJ, Moro MJ, Díaz-Curiel M, Alegre J, Malouf J, Del Pino J, Nogués X, Torrijos A; GIUMO Cooperative Group. Sosa M, et al. Among authors: malouf j. Aging Clin Exp Res. 2011 Apr;23(2):112-7. doi: 10.3275/7041. Epub 2010 May 12. Aging Clin Exp Res. 2011. PMID: 20463439
Prevalence of vertebral fracture in postmenopausal women with lumbar osteopenia using MorphoXpress® (OSTEOXPRESS Study).
Arboleya L, Díaz-Curiel M, Del Río L, Blanch J, Díez-Pérez A, Guañabens N, Quesada JM, Sosa M, Gómez C, Muñoz-Torres M, Ramírez E, Combalia J; OSTEOXPRESS study investigators. Arboleya L, et al. Aging Clin Exp Res. 2010 Oct-Dec;22(5-6):419-26. doi: 10.1007/BF03337737. Epub 2010 Jan 28. Aging Clin Exp Res. 2010. PMID: 20110769
SNPs in bone-related miRNAs are associated with the osteoporotic phenotype.
De-Ugarte L, Caro-Molina E, Rodríguez-Sanz M, García-Pérez MA, Olmos JM, Sosa-Henríquez M, Pérez-Cano R, Gómez-Alonso C, Del Rio L, Mateo-Agudo J, Blázquez-Cabrera JA, González-Macías J, Pino-Montes JD, Muñoz-Torres M, Diaz-Curiel M, Malouf J, Cano A, Pérez-Castrillon JL, Nogues X, Garcia-Giralt N, Diez-Perez A. De-Ugarte L, et al. Among authors: malouf j. Sci Rep. 2017 Mar 31;7(1):516. doi: 10.1038/s41598-017-00641-7. Sci Rep. 2017. PMID: 28364128 Free PMC article.
Genetic analysis of high bone mass cases from the BARCOS cohort of Spanish postmenopausal women.
Sarrión P, Mellibovsky L, Urreizti R, Civit S, Cols N, García-Giralt N, Yoskovitz G, Aranguren A, Malouf J, Di Gregorio S, Río LD, Güerri R, Nogués X, Díez-Pérez A, Grinberg D, Balcells S. Sarrión P, et al. Among authors: malouf j. PLoS One. 2014 Apr 15;9(4):e94607. doi: 10.1371/journal.pone.0094607. eCollection 2014. PLoS One. 2014. PMID: 24736728 Free PMC article.
Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates.
Miller PD, Pannacciulli N, Brown JP, Czerwinski E, Nedergaard BS, Bolognese MA, Malouf J, Bone HG, Reginster JY, Singer A, Wang C, Wagman RB, Cummings SR. Miller PD, et al. Among authors: malouf j. J Clin Endocrinol Metab. 2016 Aug;101(8):3163-70. doi: 10.1210/jc.2016-1801. Epub 2016 Jun 6. J Clin Endocrinol Metab. 2016. PMID: 27270237 Free PMC article. Clinical Trial.
10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension.
Bone HG, Wagman RB, Brandi ML, Brown JP, Chapurlat R, Cummings SR, Czerwiński E, Fahrleitner-Pammer A, Kendler DL, Lippuner K, Reginster JY, Roux C, Malouf J, Bradley MN, Daizadeh NS, Wang A, Dakin P, Pannacciulli N, Dempster DW, Papapoulos S. Bone HG, et al. Among authors: malouf j. Lancet Diabetes Endocrinol. 2017 Jul;5(7):513-523. doi: 10.1016/S2213-8587(17)30138-9. Epub 2017 May 22. Lancet Diabetes Endocrinol. 2017. PMID: 28546097 Clinical Trial.
Comparative effects of teriparatide and strontium ranelate in the periosteum of iliac crest biopsies in postmenopausal women with osteoporosis.
Ma YL, Marin F, Stepan J, Ish-Shalom S, Möricke R, Hawkins F, Kapetanos G, de la Peña MP, Kekow J, Martínez G, Malouf J, Zeng QQ, Wan X, Recker RR. Ma YL, et al. Among authors: malouf j. Bone. 2011 May 1;48(5):972-8. doi: 10.1016/j.bone.2011.01.012. Epub 2011 Jan 22. Bone. 2011. PMID: 21262402 Clinical Trial.
Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial.
Langdahl BL, Libanati C, Crittenden DB, Bolognese MA, Brown JP, Daizadeh NS, Dokoupilova E, Engelke K, Finkelstein JS, Genant HK, Goemaere S, Hyldstrup L, Jodar-Gimeno E, Keaveny TM, Kendler D, Lakatos P, Maddox J, Malouf J, Massari FE, Molina JF, Ulla MR, Grauer A. Langdahl BL, et al. Among authors: malouf j. Lancet. 2017 Sep 30;390(10102):1585-1594. doi: 10.1016/S0140-6736(17)31613-6. Epub 2017 Jul 26. Lancet. 2017. PMID: 28755782
152 results